Total mortality · People with primary squamous cell carcinoma of the oral cavity (ICD-O C01-C06) or oropharynx (ICD-O C09-C10); head and neck cancer trials…
Pre-operative and post-operative radiotherapy showed no clear difference in total mortality compared with post-operative radiotherapy alone; GRADE not reported.
1 finding from 1 review
HR 0.67 [0.35, 1.28]
1 study
GRADE not reported
Altered fractionation radiotherapy plus chemotherapy vs Chemoradiotherapy with standard (conventional) fractionation
Outcome not reported · People with primary squamous cell carcinoma of the oral cavity (ICD-O C01-C06) or oropharynx (ICD-O C09-C10); head and neck cancer trials…
The review found no eligible studies for this question.
1 finding from 1 review
Disease-free survival · People with primary squamous cell carcinoma of the oral cavity (ICD-O C01-C06) or oropharynx (ICD-O C09-C10); head and neck cancer trials…
1 finding from 1 review
Accelerated vs conventional, disease free survival: both trials reported this, but substantial clinical and statistical heterogeneity (P = 0.0004, I2 = 92%) meant a pooled analysis was not reported (Analysis 1.3).
2 studies
GRADE not reported
Disease-free survival · People with primary squamous cell carcinoma of the oral cavity (ICD-O C01-C06) or oropharynx (ICD-O C09-C10); head and neck cancer trials…
1 finding from 1 review
Overall symptoms, pain and headache (relief from symptoms assessed by global measures) · Adults aged 18 years or older with clinically diagnosed TMD (exhibiting two or more of the listed signs and/or symptoms)
The review found no eligible studies for this question.
1 finding from 1 review
Locoregional control · People with primary squamous cell carcinoma of the oral cavity (ICD-O C01-C06) or oropharynx (ICD-O C09-C10); head and neck cancer trials…
Pre-operative radiotherapy (plus surgery) showed no clear difference in locoregional control compared with surgery alone; GRADE not reported.
1 finding from 1 review
RR 0.63 [0.28, 1.46]
1 study
GRADE not reported
Altered fractionation radiotherapy vs Chemoradiotherapy (concurrent, standard fractionation)
Outcome not reported · People with primary squamous cell carcinoma of the oral cavity (ICD-O C01-C06) or oropharynx (ICD-O C09-C10); head and neck cancer trials…
The review found no eligible studies for this question.
1 finding from 1 review
Tactile sensitivity (method a, ordinal scale) · Healthy human adults (18 years or more) with dentine hypersensitivity from exposed root surfaces
Potassium containing toothpaste (5% potassium nitrate) led to lower tactile sensitivity (method a, ordinal scale) compared with control toothpaste (without potassium); GRADE not reported.
1 finding from 1 review
MD -0.65 [-1.07, -0.23]
1 study
GRADE not reported
Thermal sensitivity · Healthy human adults (18 years or more) with dentine hypersensitivity from exposed root surfaces
Potassium containing toothpaste (5% potassium nitrate) led to lower thermal sensitivity compared with control toothpaste (without potassium); GRADE not reported.
1 finding from 1 review
MD -1.10 [-1.64, -0.55]
1 study
GRADE not reported
Subjective assessment of sensitivity · Healthy human adults (18 years or more) with dentine hypersensitivity from exposed root surfaces
Potassium containing toothpaste (5% potassium nitrate) showed no clear difference in subjective assessment of sensitivity compared with control toothpaste (without potassium); GRADE not reported.
1 finding from 1 review
Air blast sensitivity · Healthy human adults (18 years or more) with dentine hypersensitivity from exposed root surfaces
Potassium containing toothpaste (5% potassium nitrate) led to lower air blast sensitivity compared with control toothpaste (without potassium); GRADE not reported.
1 finding from 1 review
Tactile sensitivity (method b, continuous probe) · Healthy human adults (18 years or more) with dentine hypersensitivity from exposed root surfaces
Potassium containing toothpaste (5% potassium nitrate) led to higher tactile sensitivity (method b, continuous probe) compared with control toothpaste (without potassium); GRADE not reported.
1 finding from 1 review
Intervention not reported
Global cognitive function measured at the end of the intervention period (12 weeks) · cognitively healthy people in late life
1 finding from 1 review
Intervention not reported
Cognitive subdomain: speed of processing measured at the end of the intervention period (12 to 16 weeks) · cognitively healthy people in late life
1 finding from 1 review
Intervention not reported
Cognitive subdomain: executive functioning measured at the end of the intervention period (12 weeks to 6 months) · cognitively healthy people in late life
1 finding from 1 review
Intervention not reported
Cognitive subdomain: working memory measured at the end of the intervention period (16 weeks) · cognitively healthy people in late life
1 finding from 1 review
Intervention not reported
Cognitive subdomain: verbal fluency measured at the end of the intervention period (6 months) · cognitively healthy people in late life
1 finding from 1 review
Intervention not reported
Quality of life at the end of the intervention period · cognitively healthy people in late life
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Cognitive subdomain: episodic memory measured at the end of the intervention period (12 to 17 weeks) · cognitively healthy people in late life
1 finding from 1 review
Intervention not reported
Cognitive subdomain: speed of processing measured at the end of the intervention period (12 to 16 weeks) · cognitively healthy people in late life
1 finding from 1 review